In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acologix Inc.

www.acologix.com

Latest From Acologix Inc.

Mitsubishi Tanabe picks up North American rights to Toray's nalfurafine

Mitsubishi Tanabe Pharma (MTP) has acquired for undisclosed terms the development and commercialisation rights in North America to Toray's nalfurafine (TRK-820).

Cardiovascular Dermatology

Specialty Pharma: Tapping Japan

Economic recovery, pharmaceutical consolidation, and a burgeoning private equity sector have encouraged a new cluster of Japan-focused specialty pharmas
BioPharmaceutical North America
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Dental & Oral Products
  • Musculoskeletal & Connective Tissue Disorders
  • Renal System
  • Alias(es)
  • Big Bear Bio Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Acologix Inc.
  • Senior Management
  • Yoshinari Kumagai, Pres. & CEO
    John J Buckely, CFO
    David M Rosen, PhD, VP, R&D
    Keith Lenden, Dir., Bus. Dev.
  • Contact Info
  • Acologix Inc.
    Phone: (510) 512-7200
    3960 Point Eden Way
    Hayward, CA 94545
    USA
UsernamePublicRestriction

Register